期刊文献+

癫痫患者CYP2C19基因多态性分析 被引量:5

Genetic polymorphism analysis of CYP2C19 in patients with epilepsy
下载PDF
导出
摘要 目的研究癫痫患者CYP2C19基因多态性。方法运用PCR-RFLP方法对67例应用丙戊酸的癫痫患者的CYP2C19*2和CYP2C19*3位点进行基因型分析。结果两个位点共有5种基因型组合:681GG-636GG、681GA-636GG、681GG-636GA、681AA-636GG、681GA-636GA。快代谢者(EMs)包括681GG-636GG、681GA-636GG、681GG-636GA基因型,分布频率为86.57%;慢代谢者(PMs)包括681AA-636GG、681GA-636GA基因型,分布频率为13.43%。结论PMs发生率与国内报道相近,CYP2C19基因多态性分析有助于丙戊酸的临床合理应用。 Objective To investigate the genetic polymorphism of CYP2Ct9 in patients with epilepsy. Methods CYP2C19 variants ( * 2 and * 3 ) were detected by PCR-RFLP method in 67 patients taking valproic acid. Results We found that there were five genotypes of CYP2C19 in these subjects,and that the frequencies of Extensive Metabolizers (EMs)were 86. 57% and the frequencies of Poor Metabolizers (PMs)were 13.43%. Conclusion The frequencies of PMs are similar to the data of the report. The genetic polymorphism analysis of CYP2C19 is helpful for the reasonable use of valproic acid.
出处 《中国实用医药》 2010年第5期51-52,共2页 China Practical Medicine
基金 广州市医药卫生科技项目(项目编号:2007-YB-212)
关键词 CYP2C19 癫痫 丙戊酸 PCR-RFLP CYP2C 19 Epilepsy Valproic acid PCR-RFLP
  • 相关文献

参考文献3

二级参考文献35

  • 1齐晓涟,黄越,王育琴,陈彪.苯妥英钠血药浓度与CYP2C19基因多态性关系的研究[J].中国新药杂志,2004,13(10):922-925. 被引量:14
  • 2陈华芳,史习舜.细胞色素氧化酶P4502C19的研究进展[J].中国肿瘤,2006,15(2):116-119. 被引量:4
  • 3王凌霄,苗玲.难治性癫痫的耐药机制[J].上海交通大学学报(医学版),2006,26(11):1306-1309. 被引量:3
  • 4国家药典委员会编.中国药典2000年版临床用药须知 第3版[M].北京:化学工业出版社,2001.74.
  • 5于洁,邵宏,聂小燕,郭金凤,周颖,崔一民,史录文.CYP2C19基因多态性对癫痫患者丙戊酸血药浓度的影响[J].中国临床药理学与治疗学,2007,12(6):700-704. 被引量:23
  • 6De Morais S, Wilkinmn GR, Blaisdell J. et al. The major genetic defect responsible for the polymorphism of S - mephenytoin metabolism in humans [J]. J Biol Chem, 1994, 269(22): 15419-15422.
  • 7Kunihiko IT, Kazuyuki IN, Hiroshi NK, et al. Polymerase Chain Reaction-Single-Strand conformation po|ymorphism based determination of two major genetic defects responsible for a phenotypic polymorphism of cytochrome P450 (CYP) 2C19 in the japanese population[J ]. Analytical Biochemistry, 2000, 284( 1 ) :160.
  • 8Kristensen VN, Kelefiotis D, Kristensen T, et al. High-throughput methods for detection of genetic variation[J]. Biotechniques 2001,30(2) :318,324,326.
  • 9Wroblewski B,Glenn MB.The cytochrome P450 drug metabolizing enzyme system:an overview of potential clinicially important drug interactions[J].J Head Trauma Rebabil,2002;17:571-574.
  • 10Wedlund PJ,Aslanian WS,McAllister CB,et al.Mephenytoin hydroxylation deficiency in Caucasians:frequency of a new oxidative drug metabolism polymorphism[J].Clin Pharmacol Ther,1984;36:773-780.

共引文献116

同被引文献45

引证文献5

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部